JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ALOG
3376
DELISTED
Analogic Corp
ALOG
| $714K | ﹤0.01% |
9,826
-4,934
| -33% | -$354K |
2014 Q4
10 quarters
|
|
3377
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.03B
| $713K | ﹤0.01% |
50,873
-4,480,200
| -99% | -$63.9M |
2013 Q2
16 quarters
|
|
3378
PUT
Boeing
BA
$152B
| $712K | ﹤0.01% |
+3,600
| New | +$670K |
2017 Q2
0 quarters
|
|
3379
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.36B
| $712K | ﹤0.01% |
12,817
-76
| -0.6% | -$4.14K |
2013 Q2
16 quarters
|
|
3380
Westwood Holdings Group
WHG
$182M
| $712K | ﹤0.01% |
12,562
-2,940
| -19% | -$163K |
2016 Q3
3 quarters
|
|
|
ENLC
3381
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $712K | ﹤0.01% |
40,426
-99,478
| -71% | -$1.77M |
2013 Q2
16 quarters
|
|
3382
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.95B
| $711K | ﹤0.01% |
6,233
-333
| -5% | -$35.8K |
2013 Q2
16 quarters
|
|
3383
CALL
Cognizant
CTSH
$26.2B
| $710K | ﹤0.01% |
10,700
-5,600
| -34% | -$356K |
2017 Q1
1 quarter
|
|
3384
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
| $709K | ﹤0.01% |
10,200
+448
| +5% | +$30.7K |
2013 Q2
16 quarters
|
|
3385
Bio-Techne
TECH
$11.4B
| $709K | ﹤0.01% |
24,136
+20,984
| +666% | +$574K |
2015 Q3
7 quarters
|
|
3386
State Street SPDR S&P Telecom ETF
XTL
$554M
| $709K | ﹤0.01% |
10,029
+4,308
| +75% | +$306K |
2016 Q1
5 quarters
|
|
|
OLBK
3387
DELISTED
Old Line Bancshares, Inc.
OLBK
| $709K | ﹤0.01% |
25,145
-4,527
| -15% | -$126K |
2016 Q4
2 quarters
|
|
|
WW
3388
DELISTED
WW International
WW
| $706K | ﹤0.01% |
21,122
-33,827
| -62% | -$817K |
2016 Q2
4 quarters
|
|
3389
AMERISAFE
AMSF
$432M
| $702K | ﹤0.01% |
12,340
-18,264
| -60% | -$1.04M |
2013 Q2
16 quarters
|
|
3390
UNIFI
UFI
$119M
| $702K | ﹤0.01% |
22,780
-13,750
| -38% | -$388K |
2013 Q2
16 quarters
|
|
|
CORV
3391
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $701K | ﹤0.01% |
155,095
+42,416
| +38% | +$154K |
2015 Q4
6 quarters
|
|
|
ENDP
3392
PUT
DELISTED
Endo International plc
ENDP
| $698K | ﹤0.01% |
+62,500
| New | +$734K |
2017 Q2
0 quarters
|
|
|
JCP
3393
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
| $698K | ﹤0.01% |
150,000
-150,000
| -50% | -$767K |
2017 Q1
1 quarter
|
|
3394
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
| $691K | ﹤0.01% |
15,532
+198
| +1% | +$8.82K |
2013 Q2
16 quarters
|
|
3395
Glaukos
GKOS
$9.67B
| $687K | ﹤0.01% |
16,582
-15,427
| -48% | -$665K |
2016 Q1
5 quarters
|
|
3396
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$1.98B
| $685K | ﹤0.01% |
31,110
+7,677
| +33% | +$168K |
2015 Q2
8 quarters
|
|
3397
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.29B
| $685K | ﹤0.01% |
12,160
+2,788
| +30% | +$154K |
2015 Q3
7 quarters
|
|
3398
CALL
Lowe's Companies
LOW
$101B
| $682K | ﹤0.01% |
8,800
-1,441,200
| -99% | -$118M |
2016 Q4
2 quarters
|
|
3399
John Hancock Multifactor Large Cap ETF
JHML
$1.18B
| $681K | ﹤0.01% |
+21,539
| New | +$674K |
2017 Q2
0 quarters
|
|
3400
Tootsie Roll Industries
TR
$2.83B
| $680K | ﹤0.01% |
25,460
-24,512
| -49% | -$681K |
2013 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.